公司资料
Astria Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- ATXS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for ATXS.
公司概览
业务概览
Astria Therapeutics is a biotechnology company focused on allergic and immunologic diseases, especially hereditary angioedema and related conditions. Its story is built around addressing chronic immune-mediated disorders with focused biologics.
所在地与行业分类
Astria is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
商业模式特征
The company depends on clinical progress, regulatory milestones, and the ability to build a durable rare-disease franchise. Investors watch efficacy, safety, and commercial readiness.
生物医药行业定位
Astria occupies a high-value immunology niche within biotech. The stock is catalyst-sensitive because a narrow set of milestones can materially change the long-term outlook.
未来催化剂
- Astria’s catalysts are navenibart and the hereditary-angioedema program, where the next update can materially affect the story. The company still needs clinical proof.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。